SCHEMBL26686303

SCHEMBL26686303

Nc1cn(C2CCCCO2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
TP53 P04637 1/20 0.41
CYP2C9 P11712 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
APEX1 P27695 1/20 0.41
PI4KA P42356 1/20 0.41
BLM P54132 1/20 0.41
ADCY1 Q08828 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
CYP2C19 P33261 1/20 0.39
YTHDC1 Q96MU7 1/20 0.36
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25219875 0.80 CYP2C19 (0.39) ALDH1A1KMT2AMEN1TP53CYP2C9
SCHEMBL28813578 0.80 YTHDC1 (0.41) ALDH1A1KMT2AMEN1TP53CYP2C9
SCHEMBL25195947 0.74 CPB1 (0.43) ALDH1A1PI4KAPI4K2BPI4K2API4KB
SCHEMBL26686444 0.74 HTR2A (0.38) ALDH1A1KMT2AMEN1TP53CYP2C9
Hydrochloric Acid SCHEMBL20588937 0.73 CPB1 (0.42) ALDH1A1PI4KAPI4K2BPI4K2API4KB
SCHEMBL25199851 0.73 CPB1 (0.44) ALDH1A1PI4KAPI4K2BPI4K2API4KB
Hydrochloric Acid SCHEMBL23389336 0.72 CPB1 (0.43) ALDH1A1PI4KAPI4K2BPI4K2API4KB
SCHEMBL23693245 0.71 CYP2C19 (0.36) ALDH1A1KMT2AMEN1TP53CYP2C9
SCHEMBL24925589 0.71 CPB1 (0.40) PI4KAPI4K2BPI4K2API4KB
SCHEMBL12525140 0.70 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1TP53CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304576-A1 IKK INHIBITORS CANCER RESEARCH TECH LTD (GB) 2025-10-02 US disclosed
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 EP disclosed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 CN disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 WO disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304576-A1 IKK INHIBITORS NFKBIA, IKBKE, IKBKB ALDH1A1 4083/4885KMT2A 1492/4885MEN1 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.